Hyasynth Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 13

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 4

Hyasynth General Information

Description

Producer of cannabinoid products intended to treat biosynthesis problems and contribute to healthcare benefits. The company's products are made using technologies from traditional and modern biology combined with computational insights to develop organisms and treat multiple sclerosis, epilepsy, and Alzheimer's diseases, enabling patients to get access to products that can help improve their health.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 141 Avenue Du Président-Kennedy
  • Local SB-5230, Casier 1
  • Montreal, Quebec H2X 1Y4
  • Canada
+1 (514)
Primary Industry
Other Pharmaceuticals and Biotechnology
Corporate Office
  • 141 Avenue Du Président-Kennedy
  • Local SB-5230, Casier 1
  • Montreal, Quebec H2X 1Y4
  • Canada
+1 (514)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Hyasynth Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
13. Secondary Transaction - Private Completed Generating Revenue
12. Accelerator/Incubator 12-Apr-2024 Completed Generating Revenue
11. Later Stage VC (Series A) 01-Sep-2019 Completed Generating Revenue
10. Accelerator/Incubator 01-Jan-2019 Completed Generating Revenue
9. Early Stage VC (Series B1) 23-Oct-2017 Completed Generating Revenue
8. Accelerator/Incubator 31-Jan-2017 Completed Generating Revenue
7. Accelerator/Incubator 13-Jul-2016 Completed Startup
6. Accelerator/Incubator 29-Jun-2015 Completed Startup
5. Accelerator/Incubator 13-Jan-2015 $60K Completed Startup
4. Grant $60K Completed Startup
To view Hyasynth’s complete valuation and funding history, request access »

Hyasynth Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Producer of cannabinoid products intended to treat biosynthesis problems and contribute to healthcare benefits. The comp
Other Pharmaceuticals and Biotechnology
Montreal, Canada
13 As of 2023

Hoofddorp, Netherlands
 

Chicago, IL
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Hyasynth Competitors (2)

One of Hyasynth’s 2 competitors is Endoca, a Corporation company based in Hoofddorp, Netherlands.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Endoca Corporation Hoofddorp, Netherlands
PharmaCann Venture Capital-Backed Chicago, IL
You’re viewing 2 of 2 competitors. Get the full list »

Hyasynth Patents

Hyasynth Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2021384448-A1 Cannabidiolic acid synthase variants with improved activity for use in production of phytocannabinoids Pending 20-Nov-2020
CA-3196893-A1 Cannabidiolic acid synthase variants with improved activity for use in production of phytocannabinoids Pending 20-Nov-2020
EP-4247955-A1 Cannabidiolic acid synthase variants with improved activity for use in production of phytocannabinoids Inactive 20-Nov-2020
EP-4247955-A4 Cannabidiolic acid synthase variants with improved activity for use in production of phytocannabinoids Inactive 20-Nov-2020
US-20220290194-A1 Cannabidiolic acid synthase variants with improved activity for use in production of phytocannabinoids Inactive 20-Nov-2020 C12Y121/03008
To view Hyasynth’s complete patent history, request access »

Hyasynth Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Hyasynth Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Keihanna Global Acceleration Program Accelerator/Incubator
Organigram Global Corporation
iGem Startups Accelerator/Incubator
BoxOne Ventures Venture Capital Minority
To view Hyasynth’s complete investors history, request access »

Hyasynth FAQs

  • When was Hyasynth founded?

    Hyasynth was founded in 2014.

  • Where is Hyasynth headquartered?

    Hyasynth is headquartered in Montreal, Canada.

  • What is the size of Hyasynth?

    Hyasynth has 13 total employees.

  • What industry is Hyasynth in?

    Hyasynth’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is Hyasynth a private or public company?

    Hyasynth is a Private company.

  • What is Hyasynth’s current revenue?

    The current revenue for Hyasynth is .

  • How much funding has Hyasynth raised over time?

    Hyasynth has raised $11.6M.

  • Who are Hyasynth’s investors?

    Keihanna Global Acceleration Program, Organigram Global, iGem Startups, and BoxOne Ventures have invested in Hyasynth.

  • Who are Hyasynth’s competitors?

    Endoca and PharmaCann are competitors of Hyasynth.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process